Nobixal (Tianeptine Sodium)

Tianeptine Sodium, the active ingredient in Nobixal, is an atypical antidepressant presented as an oral formulation for systemic use. It is indicated for the treatment of major depressive disorder in adult patients, targeting mood‑regulating neurochemical pathways and offering an alternative to conventional serotonergic agents.

GNH USA supplies Nobixal as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide in accordance with EU quality standards. The company ensures traceability, proper documentation and regulatory compliance for each shipment.

Nobixal (tianeptine sodium) acts on depressive disorders by modulating serotonin reuptake and glutamatergic transmission.

Major depressive disorder: reduces depressive symptoms and improves mood in adult patients. Persistent depressive disorder: helps alleviate chronic depressive symptoms when standard therapies are insufficient. Treatment‑resistant depression: may be considered as an alternative option after failure of conventional antidepressants.

Tianeptine sodium may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea - Headache - Dizziness - Dry mouth - Constipation - Insomnia

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Hepatic injury - Suicidal thoughts or behavior - Serotonin syndrome when combined with other serotonergic agents

When prescribing Nobixal, clinicians should observe several precautionary measures to ensure patient safety.

- Monitor hepatic function: assess liver enzymes before initiation and periodically during therapy. - Assess for suicidal ideation: evaluate mood changes, especially during early treatment. - Use caution in renal impairment: adjust monitoring as excretion may be affected. - Avoid abrupt discontinuation: taper the dose to minimize withdrawal symptoms. - Contraindicate with MAO inhibitors: do not co‑administer with monoamine oxidase inhibitors. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Tianeptine sodium can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin excess. - Selective serotonin reuptake inhibitors (SSRIs) or other serotonergic agents: potential serotonin syndrome. - Alcohol: may enhance central nervous system depression.

Moderate Interactions (Monitor Closely): - Benzodiazepines: additive sedative effects may require dose adjustment. - CYP450 inhibitors (e.g., fluoxetine, fluvoxamine): may increase tianeptine plasma levels. - Antihypertensive drugs: possible additive hypotensive effect.